Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
3billion | RCV005253393 | SCV005904666 | uncertain significance | Peroxisome biogenesis disorder 9B | 2023-12-02 | criteria provided, single submitter | clinical testing | The variant is observed at an extremely low frequency in the gnomAD v2.1.1 dataset (total allele frequency: 0.001%). Predicted Consequence/Location: Intron variant In silico tools predict the variant to alter splicing and produce an abnormal transcript [SpliceAI: 0.48 (>=0.2, moderate evidence for spliceogenicity)]. Therefore, this variant is classified as VUS according to the recommendation of ACMG/AMP guideline. |